Work

Livin promotes tumor progression through YAP activation in ovarian cancer.

Year: 2020

Type: article

Abstract: . Therefore, Livin may be a potential novel therapeutic target for the treatment of ovarian cancer.

Source: PubMed Central

Authors: Jianhua Gao, Wei Han, Yanan He, Jun Zhou, Jintian Miao, Guangmei Zhang

Institution: First Affiliated Hospital of Harbin Medical University

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3105519357

FWCI: 0.726

Cites: 44

Cited by: 11

Related to: 10